SCM
ATRS

Stonepine Capital Management’s Antares Pharma, Inc. ATRS Stock Holding History

Stonepine Capital Management’s Portfolio ATRS Stock Details ATRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
2022
Q1 		$12.8M Buy
2021
Q4 		$8.2M Buy
2021
Q3 		$961K Buy
2020
Q4 		– Sell
2020
Q3 		$3.25M Buy
2020
Q2 		– Sell
2020
Q1 		$357K Buy